Why Is Semaglutide Making Me Hungry — and Is That Normal?

Semaglutide reduces appetite primarily by acting on GLP-1 receptors in the brain and gut, but the effect can fluctuate, particularly in the days before your next injection.
Hunger returning around day five or six of a weekly dose is a well-recognised pattern and does not mean the medicine has failed.
Protein intake, meal timing and hydration all interact with how full you feel on semaglutide, diet quality matters even when appetite is reduced.
Persistent or worsening hunger that is affecting your weight or wellbeing is a clinical signal your prescriber should know about, do not adjust your dose yourself.

Feeling hungrier than expected on semaglutide is more common than most people realise. The medicine works by altering appetite signalling, but that effect isn't uniform across every day, every dose, or every person — so hunger returning at certain points in the week, or during dose changes, is a recognised pattern rather than a sign the treatment has stopped working. These medicines are prescription-only and require ongoing clinical assessment; if hunger is persistent and affecting your progress, that is exactly the kind of thing a prescriber needs to hear about. Read on for the real reasons it happens and some practical steps worth taking.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding why hunger comes back, and what you can do about it, step by step

Step 1: Work out when the hunger is hitting and why that timing matters

The first practical step is to notice the pattern. Semaglutide is injected once weekly, and its plasma concentration peaks in the day or two after the injection before gradually declining. Many people find that hunger feels well-controlled in the first half of the week and then edges back in (often on days five, six or seven) before the next dose. This is sometimes called the 'end-of-dose' effect, and it is a normal pharmacological pattern rather than evidence that the medicine is not working.

If your hunger is worst in that window, the answer is usually not a higher dose yet; it may simply reflect where you are in the titration schedule. The relationship between semaglutide and ongoing hunger tends to improve as doses increase over time, under prescriber guidance. Keeping a brief note of when hunger peaks (and what you have eaten) gives your prescriber genuinely useful information at your next review.

There is also a common misconception worth addressing gently here: if you have been wondering whether semaglutide can actually make you hungry, the honest answer is that the medicine suppresses appetite but does not eliminate the normal biology of hunger entirely. Recognising that distinction tends to reduce a lot of the anxiety around it.

Step 2: Check whether food choices are working with the medicine or against it

Semaglutide slows gastric emptying as part of its mechanism, food leaves the stomach more slowly, which is part of why people feel fuller for longer. But the composition of meals still makes a real difference to how satisfied you feel. Meals that are low in protein and fibre (or very high in refined carbohydrates) pass through the stomach and bloodstream in ways that can leave you hungry again relatively quickly, even on treatment.

Practical advice from our clinical team aligns with NHS guidance on semaglutide: eat alongside a reduced-calorie diet with adequate protein at each meal, stay well hydrated, and do not skip meals in an attempt to accelerate weight loss. Skipping meals can paradoxically trigger stronger hunger signals later in the day. For a detailed look at what to eat while on Wegovy, our dietitian-informed guide covers protein targets, meal timing and foods that tend to support appetite control on GLP-1 treatment. Small, regular meals work better for most people than large gaps between eating.

Hydration deserves a mention of its own. Dehydration and hunger can feel almost identical, and GI side effects during treatment can increase fluid losses. Aim for consistent water intake throughout the day, not just with meals.

Step 3: Know when to escalate to your prescriber rather than managing alone

Not all hunger on semaglutide is explained by timing or food choices. Sometimes it reflects a dose that is not yet at the level your body needs, the titration schedule moves gradually for tolerability reasons, so most people spend several months on doses below their eventual maintenance dose. Sometimes it reflects other factors: sleep quality, stress, and certain medications can all influence appetite independently of semaglutide's action.

If you are finding that semaglutide makes you hungry consistently throughout the week rather than just in the pre-dose window, or if it is causing you to eat significantly more than intended, tell your prescriber. According to NICE's appraisal of semaglutide for weight management (TA875), the goal is to reach the highest tolerated maintenance dose within a structured programme. Stalling well below that, with ongoing hunger undermining your efforts, is a clinical conversation, not a personal failing to work through alone.

At nume, sorry, at our pharmacy, a prescriber reviews every repeat order. That review is the right moment to raise exactly this kind of concern. You can also reach the aftercare team directly through our support line, which is available seven days a week.

Step 4: Consider whether this is the right medicine for your biology

A small number of people do find that semaglutide's appetite suppression is less pronounced for them than clinical trials suggest as an average. Averages always contain a spread. If you have been on a stable maintenance dose for at least three months and Wegovy is still making you hungry in a way that is persistently difficult to manage, a clinical conversation about whether the current treatment is the right fit is reasonable and appropriate.

The Wegovy overview page covers the evidence, eligibility and what to expect from treatment in fuller detail. If you are curious how semaglutide's hunger profile compares to tirzepatide's dual-pathway mechanism, our weight-loss treatment overview sets the options side by side. Switching is a decision made with a prescriber, not alone, but it is a legitimate option for people whose current treatment is not working as hoped. The consultation is free, and it is the right place to have the conversation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions